Additional information
| Active substance | Solifenacin |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Not routinely required |
| Also known as | YM905 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant effect |
| Trade name | VESIcare |
| Storage conditions | Store at 20-25В°C (68-77В°F) |
| Chemical name | Solifenacin succinate |
| Formula | C23H26N2O2.C4H6O4 |
| Substance class | Antimuscarinic |
| Main action | Anticholinergic agent that reduces muscle spasms of the bladder |
| Half-life | Approximately 45-68 hours |
| Dosage (medical) | Typically 5 mg once daily, can be increased to 10 mg based on response and tolerability |
| Dosage (sports) | Not applicable |
| Effects | Reduces urgency, frequency, and leakage episodes |
| Side effects | Dry mouth, constipation, blurred vision, urinary retention |
| Use in sports | None |
| Manufacturer | Astellas |

EPO 3000iu GENERIC
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Clenbuterolhydrochlorid Sopharma
FUCIDIN 500 mg Abdi Ibragim
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS
Clexane 0.4 Sanofi
Champix 56 tabs Pfizer
Fostimon (Merional) 150 IU HMG IBSA 

Reviews
There are no reviews yet.